EUIPO trademark

Aujemflu Adjuvanted Cell - based Trivalent Influenza Vaccine

RegisteredEUIPOFigurative markClass 5

"Aujemflu Adjuvanted Cell - based Trivalent Influenza Vaccine" is a figurative mark owned by Seqirus Inc., filed at the EUIPO on September 17, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Seqirus Inc. portfolioGet this data via the API
Official EUIPO record
Aujemflu Adjuvanted Cell - based Trivalent Influenza Vaccine trademark as filed
As filed with the EUIPO
Status
Registered
Since January 15, 2026
Filed
September 17, 2025
Registered
January 11, 2026
Expires
September 17, 2035
Application no.
019247843
Registration no.
019247843
Office
EUIPO
European Union Intellectual Property Office
Mark type
Figurative mark
1 class
Ownership

Who owns Aujemflu Adjuvanted Cell - based Trivalent Influenza Vaccine

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Seqirus Inc.

231 trademarks in the portfolioView company

Representative

Baker & McKenzie Amsterdam N.V.

Baker & McKenzie Amsterdam N.V

Goods and services

What the mark covers

The products and services Aujemflu Adjuvanted Cell - based Trivalent Influenza Vaccine is filed for, grouped by Nice class.

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2026/008 Section B.1
  2. Bulletin 2025/185 Section A.1
FAQ

About Aujemflu Adjuvanted Cell - based Trivalent Influenza Vaccine

Who owns the trademark "Aujemflu Adjuvanted Cell - based Trivalent Influenza Vaccine"?

The EUIPO trademark "Aujemflu Adjuvanted Cell - based Trivalent Influenza Vaccine" (application 019247843) is owned by Seqirus Inc.

What is the status of "Aujemflu Adjuvanted Cell - based Trivalent Influenza Vaccine"?

Its status at the EUIPO is: registered.

When was "Aujemflu Adjuvanted Cell - based Trivalent Influenza Vaccine" registered?

It was registered on January 11, 2026 and is due to expire on September 17, 2035.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Aujemflu Adjuvanted Cell - based Trivalent Influenza Vaccine and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d483b-dca9-77c9-b2aa-08756e00e299
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d483b-dca9-77c9-b2aa-08756e00e299",
  "object": "trademark",
  "mark_text": "Aujemflu Adjuvanted Cell - based Trivalent Influenza Vaccine",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "019247843",
  "filing_date": "2025-09-17",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Seqirus Inc.",
      "entity_id": "ent_019eb7d7-073e-746b-967e-2a965cfa764c"
    }
  ]
}